ArticleBrain and behavior2025
Mapping Genetic Associations With Functional Brain Area Alterations in Schizophrenia and Implications for Cortical Development.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWhile prior studies have identified regional reduction in gray matter (GM) volume in schizophrenia, it remains unclear whether these alterations are concentrated in specific brain functional areas and how they relate to genetic factors. This study aimed to identify Brodmann's areas (BAs) with affected GM volume in individuals with schizophrenia, explore associated genetic variants through a genome-wide association study (GWAS), and investigate the potential roles of these genes during cortical development.
methodsThe study recruited 194 individuals with schizophrenia and 330 healthy controls from the Taiwan Aging Mental Illness cohort. T1-weighted MRI scans were processed to assess GM volume changes, and the cerebral cortex was parcellated into BAs for detailed analysis. GWAS was conducted to identify schizophrenia-associated genetic variants, followed by functional mapping, single-cell RNA sequencing analysis of developing human cortical cells, and in situ hybridization analysis in the developing mouse neocortex.
resultsSignificant reductions in GM volume were found in specific BAs, particularly in the ventral frontal cortex, anterior temporal lobe, and cingulate cortex, with BA13, BA23, BA24, BA25, BA27, BA28, BA31, BA34, BA35, and BA38 showing the most pronounced changes. GWAS identified multiple genetic variants associated with these affected BAs. Further, single-cell RNA sequencing and in situ hybridization analyses revealed dynamic expression patterns of the schizophrenia-associated genes during cortical development, suggesting their potential roles in the structural abnormalities observed in schizophrenia.
conclusionsThe findings support the hypothesis that specific BAs are more vulnerable to GM volume reduction in schizophrenia, potentially driven by distinct genetic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.